Table 3.
Group | n | After 15 Treatments | 30 d After the 15th Treatment | 6 mo After the Last Treatment |
---|---|---|---|---|
Experimental | 24 | 69% (25) | 73% (23.5) | 60% (29.5) |
Control | 9 | 21% (32.2) | 26% (27.5) | |
Crossover | 8 | 24% (32.2) | 31% (32.3) |
Numbers inside parentheses indicate the standard deviation.